Structural and molecular modeling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against SARS-CoV-2 infection, Highlights  The COVID-19 pandemic caused by SARS-CoV-2 poses a global health emergency  Promising results suggest that chloroquine could stop the spread of SARS-CoV-2  In silico studies confirm the antiviral properties of chloroquine  New mechanism of action of chloroquine elucidated  Hydroxychloroquine is more potent than chloroquine
Introduction
In face of the COVID-19 pandemic due to the emergence of the new SARS-CoV-2 [1] , it is urgent to identify active antiviral compounds that can block the infection at the individual stage and stop its spread over the world. Due to the health emergency, repositioning of approved therapeutic drugs [2] has been suggested to be the most efficient way to find a cure for this virus [3] . Several drugs have already been tested, among which chloroquine (CLQ), a well-known anti-malarial drug, is one of the most promising as it has shown apparent efficacy in treatment of COVID-19 associated pneumonia in recent clinical studies [4] . However, the mechanism of action of CLQ against SARS-CoV-2 is unclear as the drug seems to exert a broad range of potential antiviral effects [5] . Therefore, although CLQ is classically considered as an inhibitor of endocytic pathways through an elevation of endosomal pH [6] , its detailed molecular mechanisms of action as an antiviral compound is still an open issue [3, 5] . Interestingly, the drug was also shown to interfere with the terminal glycosylation of angiotensin converting enzyme-2 (ACE-2) [7] , which acts as a plasma membrane receptor for both SARS-CoV [8] and SARS-CoV-2 [9] . The authors of this study concluded that CLQ could act at several steps of the coronavirus replication cycle [7] . In any case, these data suggest the interesting and mostly unexplored possibility that CLQ could prevent virus attachment through a direct effect on host cell surface molecules.
One important characteristics of human coronaviruses is that besides their protein membrane receptor, they are also depend upon sialic acid-containing glycoproteins and gangliosides that act as primary attachment factors along the respiratory tract [10] . In this report, we used a combination of structural and molecular modeling approaches [11] to investigate the potential interaction between CLQ and sialic acids. Moreover, we identified a ganglioside-binding site in the N-terminal domain (NTD) of the S glycoprotein of SARS-CoV-2 and we demonstrated that CLQ is a potential blocker of the spike-ganglioside interaction which occurs at the very first step of the viral infection cycle. Finally, we compared the antiviral potential of CLQ and its derivative hydroxychloroquine (CLQ-OH) against SARS-CoV-2. Overall, these data confirm that CLQ and CLQ-OH might be used to fight pathogenic human coronaviruses [3] [4] [5] [6] , especially SARS-CoV-2 [12] .
Materials and Methods
In silico analyses were performed using Hyperchem and Molegro Molecular viewer as described [11, 13, 14] . The initial coordinates of GM1 were obtained from CHARMM-GUI Glycolipid Modeler (http://www.charmmgui.org/?doc=input/glycolipid; [15] ) which uses the internal coordinate information of common glycosidic torsion angle values, orients the ganglioside perpendicular to the membrane, and performs Langevin dynamics with a cylindrical restraint potential to keep the whole GM1 molecule cylindrical, especially the membrane-embedded ceramide part. In the next step, we included the ganglioside in a periodic box solvated with 1128 water molecules. The system was energy-minimized 6 times switching alternatively between runs using steepest descent gradients or Polak-Ribière conjugate gradients until convergence to machine precision. The ganglioside was then merged with the NTD domain of SARS-CoV-2 S protein as obtained from pdb file # 6VSB [16] .
Initial conditions corresponded to minimized structures obtained with the Polak-Ribière algorithm. Docked complexes were subsequently submitted to iterative cycles of molecular dynamics using the CHARMM36 force field optimized for carbohydrates [17] . Interaction energies were calculated from stable complexes using the Ligand Energy Inspector function of Molegro [13] .
N-Acetylneuraminic acid (Neu5Ac) was generated with the Hyperchem database. 9-O-acetyl-N-acetylneuraminic acid (9-O-SIA), was retrieved from pdb file 6Q06 [18] . Chloroquine (CLQ) is N-(7-chloroquinolin-4-yl)-N,N-diéthyl-pentane-1,4-diamine. Its 3D structure was retrieved from pdb file # 4V2O [19] . Hydroxychloroquine (CLQ-OH) is (RS)-2-[{4-[(7chloroquinolin-4-yl)amino]pentyl}(ethyl)amino]ethanol. CLQ-OH was generated by hydroxylation of CLQ with Hyperchem. Both CLQ and CLQ-OH were energy minimized and merged with water molecules as described in the Results section.
Results

Structural and conformational analysis of CLQ and CLQ-OH in water
The chemical structures of CLQ and CLQ-OH are shown in Figure 1a and 1b, respectively.
The only difference between both molecules is the presence of a terminal hydroxyl group in CLQ-OH. This OH group has a marked influence on the conformation and the water solubilization properties of the drug. CLQ-OH may adopt a wide range of conformations, the most stable being the extended one shown in Figure 1c . When immersed in a periodic box of 31.5 Å 2 with 1042 water molecules, the system reached, at the equilibrium, an energy of interaction estimated to -92 kJ.mol -1 , accounting for 56 water molecules solvating CLQ-OH ( Figure 1d ). In contrast, due to and intramolecular hydrophobic effect, CLQ appeared more condensed than CLQ-OH ( Figure 1e ). At equilibrium, CLQ was surrounded by 58 water molecules with an energy of interaction of -79 kJ.mol -1 (Figure 1f ).
We used these water compatible conformations of CLQ and CLD-OH as initial conditions for studying the interaction of these drugs with sialic acids and gangliosides.
Sialic acids as molecular targets of CLQ and CLQ-OH
N-Acetylneuraminic acid (Neu5Ac) is the predominant sialic acid found in human glycoproteins and gangliosides. When CLQ was merged with Neu5Ac, a quasi-instantaneous fit occurred between both molecules whose global shapes in water are complementary geometrically (Figure 2a ). This is particularly obvious in the views of the CLQ-Neu5Ac complex in mixed surface/balls & sticks rendition (Figure 2a and 2b). The interaction was driven by the positioning of the negative charge of the carboxylate group of Neu5Ac and one of the two cationic charges of CLQ (pKa 10.2) ( Figure 2c ). The energy of interaction of this complex was estimated to -47 kJ.mol -1 . Since coronavirus preferentially interact with 9-Oacetyl-N-acetylneuraminic acid (9-O-SIA) [10] , we used a similar molecular modeling approach to assess whether CLQ could also interact with this specific sialic acid. A good fit between CLQ and 9-O-SIA could be obtained (Figure 2d Then we tested CLQ-OH to assess whether it could, as CLQ, bind to 9-O-SIA ( Figure 3 ). The complex obtained with CLQ-OH was very similar to the one obtained with CLQ (e.g.
compare Figure 3a which is very close to the value obtained for CLQ (-45 kJ.mol -1 ).
Molecular recognition of gangliosides by CLQ and CLQ-OH
In the respiratory tract, sialic acids are usually part of glycoproteins and gangliosides. In order to assess whether CLQ and CLQ-OH can recognize sialic acid units in their natural molecular environment. In these simulations, ganglioside GM1 was chosen as a representative example of human plasma membrane gangliosides. A first series of simulations was performed with CLQ. When merged with the ganglioside, CLQ could find two distinct binding sites, both located in the polar saccharide part of GM1. The first site was located at the tip of the saccharide moiety of the ganglioside (Figure 4a kJ.mol -1 . Interestingly, there was no overlapping between both CLQ binding sites on GM1, so that the ganglioside could accommodate two CLQ molecules (Figure 4e ), reaching a global energy of interaction of -108 kJ.mol -1 . A similar situation was observed with CLQ-OH, which occupies the same binding site as CLQ ( Figure 4f ). In this case, the energy of interaction was further increased by stabilizing contacts established between both CLQ-OH molecules, reaching -120 kJ.mol -1 . Overall, these data showed that CLQ and CLQ-OH have a good fit for sialic acids, either isolated or bound to gangliosides.
Structural analysis of the NTD of SARS-CoV-2 S protein
The next step of our study was to determine how SARS-CoV-2 could interact with plasma membrane ganglioside and whether such interaction could be affected by CLQ and CLQ-OH.
The global structure of the SARS-CoV-2 spike [16] is shown in Figure 5a The amino acid sequence of the planar interfacial surface located at the tip of the NTD was analyzed for the presence of a consensus ganglioside binding domains [20] . These motifs are constituted by a triad of mandatory amino acid residues such as (K,R)-X n -(F,Y,W)-X n -(K,R).
The X n intercalating segments, usually 4-5 residues, may contain any amino acid but often Gly, Pro and/or Ser residues. The strict application of this algorithm did allow to detect any potential ganglioside binding domain in this region of the NTD. However, there is an intriguing overrepresentation of aromatic and basic residues in the 129-158 segment:
129-KVCEFQFCNDPFLGVYYHKNNKSWMESEFR-158
This 30-amino acid stretch also contains Gly, Pro and/or Ser residues that are often found in ganglioside binding motifs. These observations supported the notion that the tip of the NTD could display a large ganglioside attachment interface.
Molecular interactions between ganglioside and the NTD of SARS-CoV-2 S protein
Molecular dynamics simulations of a structural motif encompassing amino acid residues 100 to 175 of the NTD (Figure 5f -h) merged with ganglioside GM1 further supported the concept.
As shown in Figure 6 , the large flat area of this structural domain fitted very well with the protruding oligosaccharide part of the ganglioside. Several amino acid residues appeared critical for this interaction, especially Phe-135, Asn-137, and Arg-158 (Table 1) . Overall, the complex involved 10 amino acid residues, for a total energy of interaction of -100 kJ.mol -1 . At this stage, we observed that about 50% of the interface was involved in the complex, leaving the remaining 50% available for an interaction with a second GM1 molecule. As expected, merging a second GM1 molecule with the preformed GM1-NTD complex led to a trimolecular complex consisting of two gangliosides in a typical symmetric chalice-like structure into which the NTD could insert its interfacial ganglioside binding domain ( (Table 1) .
Potential coordinated interactions between SARS-CoV-2 and the plasma membrane of a host cell: key role of gangliosides in lipid rafts
Taken together, these data strongly supported the concept of a dual receptor/attachment model for SARS-CoV-2, the RBD domain being involved I ACE-2 receptor recognition, and the NTD interface responsible for finding a ganglioside-rich landing area (lipid raft) at the cell surface.
Such a dual receptor model, consistent with the topology of the SARS-CoV-2 spike, is proposed in Figure 8 . With this model in mind, we will know study the potential effect of CLQ and CLQ-OH, which, according to our molecular modeling data, have both a high affinity for sialic acids and gangliosides.
Molecular mechanism of CLQ and CLQ-OH antiviral effect: preventing SARS-
CoV-2 spike access to cell surface gangliosides
With the aim to establish whether CLQ and CLQ-OH could prevent the attachment of SARS-CoV-2 to plasma membrane gangliosides, we superposed the initial NTD-GM1 complex with a drug-ganglioside complex (Figure 9 ). To improve clarity, the ganglioside is not presented in Figure 9 . What we can see in this superposition is that the NTD and the drugs (CLQ-OH in this case) share the same spatial position when bound to GM1, so that GM1 cannot bind at the same time the viral protein and the drug. This is due to the fact that the NTD and the drugs (CLQ and CLQ-OH) bind to GM1 with a similar mechanism controlled by a dyad of functional interactions: a hydrogen bond and a geometrically perfect CH-stacking interaction. In the case of the NTD, the hydrogen bond involves Asn-167, whereas the CHstacking is mediated by aromatic ring of Phe-135 ( Figure 6b ). On one hand, Asn-167 establishes a network of hydrogen bonds with the GalNAc residue of GM1. On the other hand, the flat aromatic ring of Phe-135 stacks onto the cycle of the Glc residue of GM1. In the case of CLQ and CLQ-OH, it is the nitrogen-containing ring of the drug that stacks onto the Glc ring ( Figure 4c ). Note that both the Phe-135 (in red) and the CLQ-OH (in green) rings are located at the same position ( Figure 9 ). The other CLQ-OH molecule, which covers the tip of the sugar part of the ganglioside interacts with the GalNAc ganglioside (Figure 4b ). When the NTD is bound to the ganglioside, we find the side chain of Asn-137 at this exact position ( Figure 9 ). Thus, once two CLQ-OH (or two CLQ) molecules are bound to a ganglioside ( Figure 4e and 4f) , any binding of a SARS-Cov-2 spike to the same ganglioside is totally prevented. The energy required to overcome this steric incompatibility could be estimated to
Sequence alignment analysis of SARS-CoV-2 and related coronavirus: evolution of the ganglioside binding domain at critical amino acid residues
Since CLQ and CLQ-OH are potential therapies for SARS-CoV-2 infection, it is important to check whether the amino acid residues identified as critical for ganglioside binding are conserved among clinical isolates. The alignment of the 111-162 domain of 11 clinical isolates of SARS-CoV-2 from various origins (including Asia and USA) is shown in Figure   10 ). In this region, which contains the ganglioside binding domain identified in the present report, all amino acids are fully conserved. Interestingly, the motif is built like a giant consensus ganglioside-binding domain: a central region displaying the critical aromatic residue (Phe-135) and a basic residue at each ending (Lys-113 and Arg-158). In the middle of each stretch separating this typical triad, there is a N-glycosylation site (Asn-122 and Asn-149). These regions are not directly involved in ganglioside binding, so that the oligosaccharide linked to these asparagine residues could be perfectly intercalated between the sugar headgroup of gangliosides.
We also noted that the ganglioside binding domain of the NTD is fully conserved in the Bat RaTG13, which indicates a close relationship between the bat coronavirus and the human isolates that are currently circulating over the world. However, the motif is slightly different in other bat and human related coronaviruses (Figure 10 ), suggesting a recent evolution which could explain, at least in part, why SARS-CoV-2 is more contagious than previously characterized human coronaviruses.
Discussion
Sialic acids linked to glycoproteins and gangliosides are used by a broad range of viruses as receptors and/or attachment factors for cell entry [10] . These viruses include major human pathogens affecting the respiratory tract such as influenza [21] and corona viruses [22, 23] .
The attachment to sialic acid-containing cell surface structures is mediated by receptor binding proteins that belong to the viral spike. In the case of coronaviruses, this function is fulfilled by the spike (S) glycoprotein [9, 24] . SARS-CoV and SARS-CoV-2 interact with the ACE-2 protein, which has been identified as a key determinant of virus contagiousness [8] .
However, considering the increased transmissibility of SARS-CoV-2 relative to SARS-CoV, binding to ACE-2 alone might not be enough to ensure a robust infection of the upper respiratory tract. Thus, it is likely that the new virus might also bind to other cell surface attachment factors, such as sialic acid-containing glycoproteins and gangliosides. Consistent with this notion, it has been shown that depletion of cell surface sialic acids by neuraminidase treatment inhibited MERS-CoV entry of human airway cells [25] . These data, which provided direct evidence that sialic acids play a critical role in human coronavirus attachment, broaden the therapeutic options to block the replication of the new virus SARS-CoV-2 that is responsible for the COVID-19 pandemic.
There are not many drugs that showed consistent antiviral efficiency in vitro together with reported efficiency in SARS-CoV-2 infected patients [3, 12] . One of them, CLQ, has retained our attention because its chemical structure is based on a combination of cationic nitrogen atoms and aromatic rings. Both features have been previously demonstrated as key determinants of sialic acid and ganglioside recognition by proteins [20, 26] . Our modeling approaches have been successfully used to decipher various molecular mechanisms of protein-sugar interactions accounting for the interaction of virus [27] , bacterial [28] , membrane [13] and amyloid proteins [20] with cell surface glycolipids. We applied this in silico strategy to unravel the molecular mechanisms underlying the antiviral mechanisms of CLQ against SARS-CoV-2 infections. First, we showed that CLQ and CLQ-OH readily bind to isolated sialic acids with high affinity, including the typical 9-O-SIA subtype recognized by coronavirus [23] . Then, we showed that CLQ and CLQ-OH also bind to sialic acid-containing gangliosides. Based on these data, one can anticipate that the drugs might also recognize the sialic acid residues of glycoproteins. Further studies will help clarify this point.
Our molecular modeling studies led us to identify of a new type of ganglioside binding domain in the NTD of the SARS-CoV-2 S protein. This ganglioside binding domain consists of a large flat interface enriched in aromatic and basic amino acid residues. It covers 52amino acid residues stretch (aa 111-162), which is definitely longer than all linear ganglioside binding domains characterized so far [29] . However, the new SARS-CoV-2 motif is organized in three distinct regions including a central aromatic domain and two terminal basic domains ( Figure 10 ). Thus, this motif displays the typical features that determine an optimal binding to gangliosides, i.e. CH-stacking and electrostatic interactions.
A major outcome of our study is the demonstration that CLQ and CLQ-OH display molecular groups that fully mimic the way the S viral protein binds to gangliosides. Two CLQ (or two CLQ-OH) molecules can simultaneously bind to the polar head group of ganglioside GM1.
Interestingly, our simulations indicated that CLQ-OH is clearly more potent than CLQ, in line with the reported increased antiviral activity of CLQ-OH against SARS-CoV-2 [30] . Once bound to GM1, the drugs prevent any access to the Glc and GalNAc units the ganglioside, which are the critical binding residues for Phe-135 and Asn-137, respectively. This amino acid dyad, as well as all the other residues that mediate ganglioside binding by the SARS-CoV-2 spike, is fully conserved among clinical isolates worldwide. It is also conserved in the bat RaTG13isolate, which reinforces the hypothesis of a bat-to-human transmission. From the epidemiology point of view, it can be hypothesized that the evolution of this motif has conferred an enhanced attachment capacity of human coronavirus to the respiratory tract, through improved spike-ganglioside interactions.
Conclusion
In face of the worldwide health emergency, drug repurposing is obviously the option of choice [2, 3] . However, we could save a lot of time by testing in silico the capability of any potential anti-SARS-CoV-2 to block the very first step of the viral cycle. Applied to both RBD-ACE-2 and NTD-ganglioside interactions, our molecular modeling method will help selecting those drugs that are likely to interfere with the initial attachment of virus particles to the respiratory tract surface epithelium. In any case, our data do support the use of CLQ and preferentially CLQ-OH as a first intention therapy for patients infected with SARS-CoV-2. In panels c and e, the chlorine atom of CLQ and CLQ-OH is indicated by an arrow. Since CLQ also interacts with the saccharide part of GM1, its presence would clearly mask most of the landing surface available for the NTD, preventing the primary attachment of the virus to the plasma membrane of host cells. Asparagine residues acting as glycosylation sites are highlighted in yellow. 
